Belite Bio (BLTE) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free BLTE Stock Alerts $36.73 +2.25 (+6.53%) (As of 03:15 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Belite Bio Short Interest DataCurrent Short Volume39,100 sharesPrevious Short Volume59,500 sharesChange Vs. Previous Month-34.29%Dollar Volume Sold Short$1.50 millionShort Interest Ratio / Days to Cover0.6Last Record DateMarch 31, 2024Outstanding Shares29,149,000 sharesPercentage of Shares Shorted0.13%Today's Trading Volume22,816 sharesAverage Trading Volume58,532 sharesToday's Volume Vs. Average39% Short Selling Belite Bio ? Sign up to receive the latest short interest report for Belite Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBLTE Short Interest Over TimeBLTE Days to Cover Over TimeBLTE Percentage of Float Shorted Over Time Ad DTIHere’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.Weekend after weekend! Belite Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202439,100 shares $1.50 million -34.3%N/A0.6 $38.37 3/15/202459,500 shares $2.29 million +20.7%N/A0.8 $38.47 2/29/202449,300 shares $2.28 million +4.5%N/A0.6 $46.25 2/15/202447,200 shares $2.27 million -11.3%N/A0.5 $48.00 1/31/202453,200 shares $2.31 million -6.0%N/A0.5 $43.43 1/15/202456,600 shares $2.59 million +40.8%N/A0.4 $45.81 Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 12/31/202340,200 shares $1.84 million -47.9%N/A0.3 $45.75 12/15/202377,100 shares $3.46 million +19.5%N/A0.6 $44.83 11/30/202364,500 shares $2.71 million -26.3%N/A0.5 $42.07 11/15/202387,500 shares $3.24 million -9.7%N/A0.7 $37.02 10/31/202396,900 shares $3.63 million +172.2%N/A0.8 $37.51 10/15/202335,600 shares $1.14 million -5.3%N/A0.4 $32.00 9/30/202337,600 shares $1.20 million -14.9%N/A0.5 $31.85 9/15/202344,200 shares $1.42 million +17.9%N/A0.5 $32.20 8/31/202337,500 shares $1.29 million +7.1%N/A0.5 $34.35 8/15/202335,000 shares $775,950.00 -24.1%N/A0.5 $22.17 7/31/202346,100 shares $1.07 million +30.6%N/A0.8 $23.22 7/15/202335,300 shares $474,432.00 -26.6%N/A0.7 $13.44 6/30/202348,100 shares $678,691.00 +13.7%N/A1.4 $14.11 6/15/202342,300 shares $607,005.00 +60.8%N/A1.4 $14.35 5/31/202326,300 shares $433,687.00 -3.3%N/A1 $16.49 5/15/202327,200 shares $639,200.00 -18.6%N/A2.3 $23.50 4/30/202333,400 shares $966,262.00 +5.4%N/A3.1 $28.93 4/15/202331,700 shares $911,375.00 +13.6%N/A3 $28.75 3/31/202327,900 shares $834,207.21 -24.4%N/A2.7 $29.90 3/15/202336,900 shares $1.13 million -4.9%N/A3.2 $30.50 2/28/202338,800 shares $1.28 million +1.8%N/A3.6 $33.10 2/15/202338,100 shares $1.22 million -8.9%N/A3 $32.00 1/31/202341,800 shares $1.25 million -52.8%N/A3.2 $29.89 1/15/202388,600 shares $2.53 million -12.1%N/A4.9 $28.50 12/30/2022100,800 shares $3.04 million -1.4%N/A4.8 $30.15 12/15/2022102,200 shares $3.04 million -13.2%N/A3.9 $29.73 11/30/2022117,800 shares $3.86 million -8.8%N/A4.1 $32.77 11/15/2022129,200 shares $3.24 million -5.3%N/A3.9 $25.10 10/31/2022136,400 shares $3.97 million +5.1%N/A3.3 $29.07 10/15/2022129,800 shares $3.60 million +3.8%N/A2.9 $27.77 9/30/2022125,100 shares $4.20 million -11.3%N/A2.1 $33.55 9/15/2022141,100 shares $5.02 million -5.5%N/A2 $35.55 8/31/2022149,300 shares $4.79 million +30.1%N/A1.7 $32.11 8/15/2022114,800 shares $3.50 million +14.1%N/A1.4 $30.50The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him BLTE Short Interest - Frequently Asked Questions What is Belite Bio's current short interest? Short interest is the volume of Belite Bio shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 39,100 shares of BLTE short. Learn More on Belite Bio's current short interest. What is a good short interest ratio for Belite Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLTE shares currently have a short interest ratio of 1.0. Learn More on Belite Bio's short interest ratio. Is Belite Bio's short interest increasing or decreasing? Belite Bio saw a decline in short interest in March. As of March 31st, there was short interest totaling 39,100 shares, a decline of 34.3% from the previous total of 59,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Belite Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Belite Bio: MacroGenics, Inc. (11.01%), Liquidia Co. (9.77%), MannKind Co. (13.21%), Immunome, Inc. (4.44%), Centessa Pharmaceuticals plc (3.08%), Arcutis Biotherapeutics, Inc. (19.89%), Mirum Pharmaceuticals, Inc. (17.36%), Prothena Co. plc (12.04%), Sage Therapeutics, Inc. (17.53%), Xencor, Inc. (9.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Belite Bio stock? Short selling BLTE is an investing strategy that aims to generate trading profit from Belite Bio as its price is falling. BLTE shares are trading up $2.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Belite Bio? A short squeeze for Belite Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLTE, which in turn drives the price of the stock up even further. How often is Belite Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLTE, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: MacroGenics Short Interest Liquidia Short Interest MannKind Short Interest Immunome Short Interest Centessa Pharmaceuticals Short Interest Arcutis Biotherapeutics Short Interest Mirum Pharmaceuticals Short Interest Prothena Short Interest Sage Therapeutics Short Interest Xencor Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLTE) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press